28 January 2025
The ATI team celebrates a double victory with prestigious funding for its innovative immunotherapy projects.
news from the crcm
28 January 2025
The Predictive Oncology team is proud to once again receive the support of the Ligue Contre le Cancer.
28 January 2025
During the event, Dr. Emilie Mamessier presented the team and its work in progress to all CRCM members, highlighting the innovative research being carried out in the fight against cancer.
28 January 2025
The Borg / Maina "Targeting signaling networks and the microenvironment in cancer" team kicks off 2025 by welcoming three Master 2 students. Saliha, Jules and Camille join our ranks!
28 January 2025
Our team recently invested in a D300e digital distributor from TECAN. This acquisition opens up new prospects for high-throughput trials and the identification of innovative treatments.
28 January 2025
Members of the Oncologie Prédictive team mobilized for "La Marseillaise des Femmes".
28 January 2025
The Predictive Oncology team was on hand to support the fight against breast cancer.
14 January 2025
Published by Poplineau et al. in 2022, the article "Noncanonical EZH2 drives retinoic acid resistance in AML by repressing retinoic acid targets" made the cover of the issue.
10 January 2025
Organized by Christophe Lachaud, the evening raised funds for the IPC, supporting the CRCM/IOC in their fight against cancer. A great success, combining solidarity and conviviality.
10 January 2025
Discover Frédéric Bard in the ARC Foundation film, which highlights his commitment and work in cancer research.
31 December 2024
Thanks to support from Cancéropole PACA, Luisa Laureti from the Pagès team is studying how single-strand DNA breaks are repaired during replication stalling, a key to a better understanding of cancers.
31 December 2024
The project entitled "How single-strand DNA gaps control the balance between faithful and mutagenic pathways of lesion tolerance" (Pagès team) has recently been awarded a three-year grant from the ARC Foundation.